No Data
PTC Therapeutics Signs Exclusive Global License And Collaboration Agreement With Novartis; PTC To Receive Upfront Payment Of $1B, Up To $1.9B In Development, Regulatory And Sales Milestones
RBC Upgrades PTC Therapeutics on 'Transformative' Novartis Deal
PTC Therapeutics Upgraded to Outperform From Sector Perform at RBC Capital
William Blair Maintains PTC Therapeutics(PTCT.US) With Buy Rating
PTC Therapeutics' Strategic Collaboration With Novartis Boosts Buy Rating
TD Cowen Maintains PTC Therapeutics(PTCT.US) With Hold Rating, Raises Target Price to $46
No Data
No Data
The Real Wojak : Do you have like a top 3-5 that you like more than all the other ones? This list is way too long
72991267 : Glad I have some $Candel Therapeutics (CADL.US)$ after my disastrous SBFM.
Rana Hasan1 : List too long